Meetings Analytics team joins ZS

Meetings Analytics, a data analytics firm that helps companies implement and improve consolidated meetings management programs, will join ZS, the global sales and marketing firm, to expand ZS’s data and analytics capabilities Founded in 2008 by Kimberly Meyer and Peter Matthews, Meetings Analytics offers business intelligence and analytics, data and compliance management and consulting services

Wenzel Spine completes buy of OsteoMed PrimaLok assets

Spinal disorder device developer Wenzel Spine said today it completed its acquisition of OsteoMed’s PrimaLok SP interspinous fusion system and FF facet fixation system. The acquired platform includes a polyaxial interspinous process device and percutaneous facet screw system for minimally invasive surgical treatments for lumbar spinal disorders, Austin, Texas-based Wenzel Spine said. “I am pleased that

Nordson and MedPlast are divvying up Vention Medical

Nordson and MedPlast are each acquiring a piece of Vention Medical in the latest M&A deal to transform the medical device contract manufacturing landscape. Nordson (Westlake, Ohio) will pay $705 million in cash to acquire Vention’s advanced technologies division, which has locations in New Hampshire, Tennessee, Ireland, Minneapolis, Massachusetts, California, Colorado and Israel. MedPlast (Tempe,

Catalent acquires softgel manufacturer Accucaps

Catalent (NYSE:CTLT) said today that it closed its acquisition of Canada-based Accucaps and its pharmaceutical soft-gel manufacturing capabilities. The Somerset, N.J.-based company did not disclose the deal’s financial details. In November, Catalent said that it planned to fund the Accucaps buy with a $400 million debt offering. Get the full story at our sister site, Drug Delivery Business News.

S&P: Medtech outlook stable, even after downgrades

The outlook for investment-grade medical device companies remains stable even after a 3-year streak of 9 consecutive downgrades, according to a new report from S&P. The downgrade of investment-grade medical device companies was mostly caused by debt-financed mergers and acquisitions, according to S&P. Factors like changes in operating performance trends and financial policy also contributed

Dow Chemical’s silicone business play: what it means for medtech

Heather Thompson, Senior Editor Dow Chemical as of mid-2016 became 100% owner of Dow Corning’s silicones business. The move created both an opportunity and challenge because it represents a marriage of organic chemistry and inorganic chemistry. How can the two complement each other and drive innovation? And how will the deal affect the medical device

How Trelleborg is getting the most out of its acquisitions

Heather Thompson, Senior Editor As is the case with many medical device industry suppliers, Trelleborg has engaged in a spate of acquisitions to broaden its offerings and better serve the growing needs of its OEM customers. Last year, Trelleborg, Sweden–based Trelleborg announced the acquisition of Tustin, California–based Specialty Silicone Fabricators. They’ve made three other acquisitions

Medacta International acquires Vivamed

Medacta International has announced its acquisition of the Austrian distributor Vivamed. The acquisition went into effect on Feb. 1. Medacta, a privately held and family-owned global designer of joint replacement and spinal surgery products, hopes to strengthen its presence in Austria and facilitate future development and investments in the market with this acquisition. It also

Inside the largest medical acquisition in history

Heather Thompson/Senior Editor Trust between Medtronic and Covidien officials helped them overcome the political blowback from the two companies’ $50 billion merger of equals, which moved Medtronic’s official headquarters from Minnesota to Ireland.  That was a major takeaway when Brett Wall, former president of Covidien and current president of the neurovascular business at Medtronic, interviewed

Vention acquires nitinol wire component maker Lithotech Medical

Vention Medical said today that it acquired Israeli nitinol wire component maker Lithotech Medical. The acquisition grows Vention’s portfolio of advanced components and tech for the development and manufacturing of medical devices. “Partnering with this talented group of nitinol experts expands our portfolio of advanced components and technologies as well as our applications expertise,” Tom

Eyewear giants Essilor, Luxottica to merge

Italian eyewear maker Luxottica (NYSE:LUX) and France’s leading lens manufacturer, Essilor (EPA:EI), have reached a €46 billion ($49 billion) agreement to merge and create a global eyewear company with annual revenue of more than €15 billion. “Finally … two products which are naturally complementary—namely frames and lenses—will be designed, manufactured and distributed under the same

Bruker expands through InVivo Biotech Services acquisition

Bruker has acquired InVivo Biotech Services (Hennigsdorf, Germany), the companies announced Wednesday. The finances of the deal were not disclosed. Bruker hopes to expand its microbiology assay with this acquisition. Bruker currently has an assay for fast identification of bacteria from positive blood cultures, the MALDI Biotyper, and hopes to expand it using InVivo Biotech’s

Steady as she goes: M&A experts weigh in on what is changing (and what isn’t)

M&A experts have some good news for medtech startups: Large companies’ appetites for acquiring new companies and technologies remains reliable as ever. Device Talks, which was held in Newport Beach, Calif., last week, featured a panel of M&A experts including advisors from Greenberg Traurig, Caldera Medical Group, Cerus and Locust Walk. The group discussed overall M&A in

Cosmed Group acquires ethylene oxide sterilization operation

Cosmed Group has bought an ethylene oxide sterilization operation from iuvo BioScience, ending an 12-year break from the marketplace. Ethylene oxide (ETO) is a colorless, flammable and explosive gas that is used as a low-temperature sterilant, according to a 2008 Disinfection and Sterilization Guideline article relayed by the CDC. Alkylation contributes to the microbicidal activity

Chinese biotech investor VIROAD takes over GILUPI

The investors AURELIA, High-Tech Gründerfonds (HTGF), KfW, ILB, the – venture capital fund of the Sparkassen of Brandenburg and Business Angels, sold their GILUPI shares to the strategic partner VIROAD. GILUPI is a company developing and manufacturing personalized cancer diagnostics in Potsdam. Due to the takeover, GILUPI gets the opportunity to continue the development of